7-12340408-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001135924.3(VWDE):āc.4280A>Gā(p.Asp1427Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,550,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 32)
Exomes š: 0.000034 ( 0 hom. )
Consequence
VWDE
NM_001135924.3 missense
NM_001135924.3 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 2.86
Genes affected
VWDE (HGNC:21897): (von Willebrand factor D and EGF domains) Predicted to enable signaling receptor binding activity. Predicted to be involved in anatomical structure development. Predicted to be active in cell surface and extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2922725).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWDE | NM_001135924.3 | c.4280A>G | p.Asp1427Gly | missense_variant | 24/29 | ENST00000275358.8 | NP_001129396.1 | |
VWDE | NM_001346972.2 | c.3935A>G | p.Asp1312Gly | missense_variant | 22/27 | NP_001333901.1 | ||
VWDE | NM_001346973.2 | c.3470A>G | p.Asp1157Gly | missense_variant | 22/27 | NP_001333902.1 | ||
VWDE | NR_144534.2 | n.5102A>G | non_coding_transcript_exon_variant | 25/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWDE | ENST00000275358.8 | c.4280A>G | p.Asp1427Gly | missense_variant | 24/29 | 5 | NM_001135924.3 | ENSP00000275358 | P1 | |
VWDE | ENST00000452576.6 | c.*1044A>G | 3_prime_UTR_variant, NMD_transcript_variant | 25/30 | 1 | ENSP00000401687 | ||||
VWDE | ENST00000521169.5 | c.*2658A>G | 3_prime_UTR_variant, NMD_transcript_variant | 21/26 | 5 | ENSP00000428810 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152100Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000192 AC: 3AN: 155874Hom.: 0 AF XY: 0.0000242 AC XY: 2AN XY: 82598
GnomAD3 exomes
AF:
AC:
3
AN:
155874
Hom.:
AF XY:
AC XY:
2
AN XY:
82598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000336 AC: 47AN: 1398660Hom.: 0 Cov.: 30 AF XY: 0.0000304 AC XY: 21AN XY: 689816
GnomAD4 exome
AF:
AC:
47
AN:
1398660
Hom.:
Cov.:
30
AF XY:
AC XY:
21
AN XY:
689816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298
GnomAD4 genome
AF:
AC:
4
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.4280A>G (p.D1427G) alteration is located in exon 24 (coding exon 24) of the VWDE gene. This alteration results from a A to G substitution at nucleotide position 4280, causing the aspartic acid (D) at amino acid position 1427 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Uncertain
D;T
Polyphen
P;.
Vest4
MutPred
Gain of disorder (P = 0.1426);.;
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at